PPARGC1A and metabolic dysfunction-associated steatotic liver disease: Clinical study also showed a significant association between genetic variations in PPARGC1A and NAFLD, which suggested PPARGC1A polymorphism and lower expression of PPARGC1A mRNA in the liver are an important genetic contribution to the etiology of NAFLD (26).